Only careful planning can prevent problems that stem from differences between a sponsor’s and a CDMO’s equipment, practices, and culture. This article highlights best practices and case studies.
Guillame Plane
Advertisement
Guillame Plane is global development and marketing manager for MilliporeSigma's BioReliance End-to-End Solutions.
Articles by Guillame Plane
Advertisement
Latest Updated Articles
A Systematic Approach to Tech Transfer and Scale-UpPublished: February 1st 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
2
PharmTech Weekly News Roundup — Week of October 27, 2025
3
Dosage Form Innovations: A CPHI Frankfurt Conversation with Lonza’s Frank Romanski, Part One
4
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
5
